Phosphate overload contributes to mineral bone disorders associated with crystal nephropathies. 47 Phytate, the major form of phosphorus in plant seeds, is known as an indigestible and negligible 48 in humans. However, the mechanism and adverse effects of high-phytate intake on Ca 2+ and 49 phosphate absorption and homeostasis are unknown. Here we show that excessive intake of 50 phytate with a low-Ca 2+ diet fed to rats contributed to the development of crystal nephropathies, 51 renal phosphate wasting, and bone loss through tubular dysfunction secondary to dysregulation of 52 intestinal calcium and phosphate absorption. Moreover, Ca 2+ supplementation alleviated the 53 detrimental effects of excess dietary phytate on bone and kidney through excretion of undigested 54 Ca 2+ -phytate, which prevented a vicious cycle of intestinal phosphate overload and renal 55 phosphate wasting while improving intestinal Ca 2+ bioavailability. Thus, we demonstrate that 56 phytate is digestible without a high-Ca 2+ diet and a risk factor for phosphate overloading and 57 developing crystal nephropathies and bone disease. 58 59 60
Introduction
Phytate (Myo-inositol hexaphosphate) is the main phosphorus storage system in plant seeds such 63 as those of cereal grains, nuts, oilseeds, and legumes (Raboy, 2000; Reddy et al., 1982) , 64 accounting for up to 80% of total phosphorous. Phytate strongly chelates essential minerals such 65 as Ca 2+ , Mg 2+ , Fe 2+ , and Zn 2+ to form mineral-phytate salts because of its six phosphate groups 66 (Kim et al., 2010; Oh et al., 2006) . These mineral-phytate salts are known to indigestible by 67 monogastric animals and humans that lack the digestive enzyme phytase, which releases 68 phosphate from mineral-phytate salts (Reddy, 2002) . The prevailing hypothesis argues that 69 phytate-derived phosphorus is indigestible, not absorbed in the intestine, and is excreted in the 70 feces (Golovan et al., 2001) . This widespread belief led to the development of low-phytate crops 71 and commercial phytases to improve the bioavailability of phytate-bound essential minerals 72 including phosphorus and to improve the nutritional quality of plant seeds (Raboy, 2007) . Thus, 73 plant seeds or high-fiber vegetable proteins represent a poor or negligible source of bioavailable 74 phosphate for intestinal absorption compared with animal proteins (Moe et al., 2011; Vervloet et 75 al., 2017) . Further, they are not considered to adversely affect intestinal phosphate absorption in 76 humans when diets mainly comprise plant-based, cereal-rich diets (Reddy, 2002) . Nonetheless, 77 there are insufficient data indicating the amount of phytate phosphorus that is bioavailable for 78 intestinal absorption and whether specific conditions can modulate the bioavailability and 79 digestibility of phytate. 80 High-phytate diets cause stronger adverse effects on Ca 2+ , iron, and zinc levels among infants, 81 young children, and pregnant and lactating women when cereal-based foods represent a large 82 percentage of the diet (Al Hasan et al., 2016; Chan et al., 2007) . Prior studies of dogs 83 demonstrate that increasing the levels of phytate reduces the intestinal absorption of Ca 2+ and 84 causes nutritional rickets (Harrison and Mellanby, 1939; Mellanby, 1949) . Likewise, increasing 85 dietary phytate is associated with secondary hyperparathyroidism in young adults because of the 86 reduced intestinal absorption of dietary Ca 2+ (Calvo et al., 1988; Pettifor, 1994) . Consistent with 87 previous observations (Ford et al., 1972; Goswami et al., 2000) , a subsequent case-control study 88 found that nutritional rickets is more prevalent in children who consume diets comprising low 89 dietary Ca 2+ and high phytate (Aggarwal et al., 2012) . These findings suggest a strong association 90 between high-phytate intake and metabolic bone diseases, including nutritional rickets and 91 osteomalacia. However, unlike the well-defined roles of phytate in mineral deficiency (Raboy, 92 2000; Reddy et al., 1982) , whether dietary phytate can modulate intestinal absorption of 93 phosphate is unknown because of a lack of awareness. 94 Despite its adverse effects on animal and human health, dietary phytate can be beneficial 95 because it inhibits digestive enzymes that hydrolyze lipids, proteins, and starch (Kumar et al., 96 2010) . For example, high-phytate diets inhibit the absorption of glucose and lipids, leading to 97 lower serum levels of glucose, triglycerides, and total cholesterol in humans (Thompson et al., 98 1987) and rodents (Kim et al., 2010; Jariwalla et al., 1990; Onomi et al., 2004) . Moreover, diets 99 based on vegetable protein lead to lower plasma levels of phosphate and fibroblast growth factor 100 23 (FGF23), a major regulator of phosphate homeostasis (Razzaque, 2009 ), compared with those 101 based on meat protein (Moe et al., 2011) . Indeed, few studies suggest that phytate diets inhibit 102 Ca 2+ induced kidney stones (Grases et al., 2000) . Unfortunately, these studies fail to contribute a 103 broader understanding of the detrimental effects of excess phytate intake on the functions of bone 104 and renal, two major organs that regulate Ca 2+ and phosphate homeostasis. 105 Here we investigated the effects of excessive intake of phytate on Ca 2+ and phosphate 106 homeostasis in a rat model, as well as in a dietary study of humans. Thus, the goals of this study 107 were to determine how a high-phytate diet affects kidney and bone health, establish whether these 108 changes depend on Ca 2+ or mineral content, and provide a rationale for restricting excessive 109 phytate intake in patients with kidney and metabolic bone diseases.
Results

112
Phytate-Fed rats develop secondary hyperparathyroidism with hypophosphatemia and azotemia 113 We previously reported that phytate forms insoluble tricalcium-or tetracalcium-phytate salts in vitro 114 over a wide pH range (Kim et al., 2010) . To evaluate the systemic effects of dietary phytate, rats (4- 115 week-old male and female Sprague Dawley) were AIN-93G diets supplemented with 0% (control), 1%, 116 3%, or 5% phytate for 12 weeks (Figure 1A) . Based on the molecular weights of Ca 2+ and phytate in 117 these diets, increased phytate supplementation at a constant Ca 2+ concentration (0.5 %) gradually 118 decreases the molar ratio of Ca 2+ /phytate (Figure 1B) . Rats fed higher levels of phytate (3% and 5%) 119 exhibited decreased growth rates, as well as reduced fat-free lean mass and whole-body fat despite 120 similar daily food intake compared with those of the control (Figure 1C-F) . We reasoned therefore that 121 the decreased growth rates were caused by decreased bioavailability of dietary Ca 2+ associated with 122 increased phytate supplementation.
123
To address this possibility, we used inductively coupled plasma mass spectroscopy (ICP-MS) to 124 analyze fecal minerals. We found that dietary phytate led to the inhibition of intestinal absorption of 125 essential minerals such as Ca 2+ , magnesium, and iron in a concentration-dependent manner ( Figure   126 1G-H-figure supplement 1A). Serum levels of Ca 2+ remained within the normal range except in rats 127 fed 5% phytate, associated with slightly reduced serum Ca 2+ (Figure 1I) . High-phytate-fed rats 128 developed hypophosphatemia ( Figure 1J ) and hypomagnesemia (Figure 1k ). Parathyroid hormone 129 (PTH) levels markedly increased (5.4-to 11.7-fold) in the high-phytate groups by week 5 (figure 130 supplement 1B) and remained elevated (2.8-to 6.4-fold) to week 12 ( Figure 1L ) in all phytate-fed rats 131 because of sustained inhibition of intestinal Ca 2+ absorption. These results suggest that PTH plays a role 132 in the development of hypophosphatemia in high-phytate-fed rats. 133 Serum levels of creatinine (Cr) remained within the normal range except in rats fed 5% phytate, 134 where Cr levels were increased compared with controls (figure supplement 1C). In contrast, serum 135 levels of blood urea nitrogen (BUN) showed a marked increase in rats fed high levels of phytate (3% 136 and 5%) compared with controls ( Figure 1M) 143 To identify the cause of azotemia, we analyzed T2-weighted magnetic resonance images (MRI) of 144 phytate-fed rats. MRI analysis revealed that rats fed 5% phytate had multiple renal cysts at the 145 corticomedullary junction (Figure 2A-figure supplement 2A) . The kidneys of these rats exhibited 146 pronounced renomegaly with pitted, irregular, and granular cortices and medullar morphology ( figure   147 supplement 2B-C). The histopathological changes in the kidneys were evaluated while blinded to the 148 experimental group and scored for overall severity of renal injury, presence and severity of renal injury, 149 Ca 2+ deposits, and fibrosis. The severity of renal injury was greatest in female rats fed 3% or 5% 150 phytate and in male rats fed 5% phytate, whereas controls lacked significant pathological changes. 151 The presence and severity of nephrocalcinosis matched the severity of renal injury scores ( Figure   152 2B-C). Pathological changes in phytate-fed rats were consistent with mild to severe crystal and bone pathology coincident with renal disease, we performed dual-energy X-ray absorptiometry 166 (pDEXA) and histological analyses of excised femora. Phytate-fed rats exhibited marked decreases in 167 the rates of bone accrual with decreased bone mineral density (BMD) in a concentration-dependent 168 manner compared with controls ( Figure 3A) . μ-CT images revealed concomitant increases in the bone 169 marrow cavity space in phytate-fed rats compared with controls ( Figure 3B) (Figure 3C) . Consistent with the trabecular bone phenotypes, phytate-fed rats had markedly reduced 173 cortical bone area (Tt.Ar) and increased cortical area fractions (Ct.Ar/Tt.Ar) ( Figure 3D) . 174 Male and female rats exhibited the same skeletal alterations, so we characterized bone 175 histopathology of the latter. Bone sections stained with Toluidine blue showed that high-phytate diets 176 decreased cartilage growth-plate thickness and bone osteoids (Figure 3E) , consistent with skeletal 177 alterations. Serum levels of receptor activator of nuclear factor kappa-B ligand (RANKL), a key 178 component of osteoclastogenesis (Kong et al., 1999) , were markedly increased in high-phytate-fed rats 179 compared with controls ( Figure 3F) . The levels of osteoprotegerin (OPG), a RANKL decoy receptor 180 that inhibits osteoclast differentiation and activation (Lacey et al., 1998) , were significantly reduced 181 ( Figure 3G) , and the sRANKL/OPG ratio was significantly increased in phytate-fed rats (Figure 3H) . 182 These data suggest a systemic acceleration of osteoclastogenesis in response to dietary phytate. 183 Analysis of bone sections stained for tartrate-resistant acid phosphatase (TRAP) revealed that 184 consumption of the high-phytate diet resulted in increased TRAP + multinucleated cells (Figure 3I) . 185 Further, bone marrow-derived stromal cell cultures exhibited a significant concentration-dependent 186 increase in the number of giant TRAP + multinucleated osteoclasts ( Figure 3J) . Together, the data led us 187 to posit that a high-phytate diet contributed to severe bone loss.
188 189
High-phytate diets dysregulate mineral and phosphate metabolism in humans 190
To determine if our findings using rats were applicable to humans, we conducted a non-comparative 191 pilot study to evaluate the short-term effects of phytate on six healthy premenopausal women (aged 23-192 34 years, body mass index, 17.7-25.8 kg/m 2 ) ( Figure 4A) 199 Urinary pH levels decreased in a dose-dependent manner as the intake of phytate increased ( Figure   200 4D). Higher dietary phytate intake resulted in a marked decrease in the 24-h urinary Ca 2+ creatinine 201 clearance rate (Figure 4E) , while the 24-h urinary phosphate creatinine clearance rate was only slightly 202 increased ( Figure 4F) . These findings are consistent with the results of the tubular reabsorption rate, 203 where high dietary phytate increases the renal tubular Ca 2+ reabsorption rate ( Figure 4G ) but decreases 204 the renal tubular phosphate reabsorption rate ( Figure 4H) . These metabolic characteristics are likely 205 secondary to the increased levels of PTH in response to high levels of dietary phytate intake ( Figure   206 4I). Further, high dietary phytate decreased the serum levels of FGF23 (figure supplement 3A) . Thus, 207 we propose that the high dietary phytate intake dysregulates mineral and phosphate metabolism in 208 humans in a manner consistent with the findings of our rat studies. 262 We next examined the morphological and histopathological changes in bones and kidneys when rats (1,25[OH] 2 D 3 ). First, we found that the serum levels of PTH were consistently elevated in rats fed the 283 HP-LCa 2+ diet compared with control rats and rats fed the HP-HCa 2+ diet (Figure 6A) . Second, we 284 found that in conjunction with high PTH, rats fed the HP-LCa 2+ diet had decreased serum levels of 285 25(OH)D 3 compared with controls ( Figure 6B) , leading to increased serum levels of 1,25(OH) 2 D 3 286 ( Figure 6C) . In rats fed the HP-HCa 2+ diet, the serum levels of 25(OH)D 3 and 1,25(OH) 2 D 3 287 normalized, indicating that Ca 2+ supplementation inhibited the metabolism of serum 25(OH)D 3 to 288 1,25(OH) 2 D 3 (Figure 6B-C) . Consistent with these findings, Ca 2+ supplementation normalized the 289 expression levels of CYP27B1, CYP24A1, and vitamin D receptor (VDR) (Figure 6D-F (Figure 7) . 336 We identified previously unrecognized mechanisms of bioavailability and digestibility of phytate is absorbed and 14% is excreted in the feces. Further, most of the radioactivity represents myo-inositol 361 or myo-inositol monophosphate in the plasma or urine (Sakamoto et al., 1993) , suggesting the phytate is 362 digestible in vivo. The biased belief that phytate is indigestible led the authors of the above two studies 363 to conclude that intact phytate is absorbed through the upper intestine, hydrolyzed within mucosal cells 364 before entry into the blood and then released as myo-inositol and phosphate into the blood or urine. 365 Subsequently, investigators who assumed that phytate is absorbed and can be detected in the blood 366 or urine (Grases et al., 2000) were unable to detect phytate in serum or urine despite using a highly 367 specific and sensitive mass spectrometry (Letcher et al., 2008) . These studies support the conclusion 368 that phosphate or myo-inositol generated by the hydrolysis of phytate hydrolysis is absorbed rather than 369 phytate, which is unabsorbable. Numerous explanations account for the impermeability of intestinal 370 membranes to phytate (Reddy, 2002) . Phytate possesses six phosphate groups with strong negative 371 charges at physiological pH, which suggests that phytate cannot cross the lipid bilayer of the plasma 372 membrane without a specific receptor (Ozaki et al., 2000) . In support of this possibility, we found that However, previous studies that investigated the effects of phytate on kidney stones in rats report 393 conflicting results, which we ascribe to differences in dietary compositions, particularly to the ratio of 394 Ca 2+ /phytate and analytical laboratory methods (Grases et al., 2000) . Specifically, the AIN-76A purified 395 rodent diet containing 1% phytate prevents the development of kidney stones compared with the AIN-396 76A controls (Grases et al., 2000) . Further, Grases et al. (17) 
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